HerAnova Lifesciences

Home
United States
Burlington, MA
HerAnova Lifesciences

Call Directions Website Contact the business

We are advancing innovative women’s health solutions with a focus on endometriosis and infertility.

10/20/2026

A fresh packaging look for HerResolve™!

The updated packaging features a refined HerAnova look for HerResolve™, our blood-based test designed to aid healthcare providers in diagnosing endometriosis.

Considering testing? Our products page includes a list of U.S. clinics offering HerResolve™.

Interested in offering HerResolve™ in your practice or have questions about accessing testing? Connect with our team through our inquiry form here: https://heranova.com/products/

We'd love to hear from you!

10/16/2026

How does IVFMD use HerResolve™ in patient care?

Katherine L. Palmerola, MD, FACOG, a board-certified OB-GYN at IVFMD in Miami, with fellowship training in Reproductive Endocrinology and Infertility, shares how she's using HerAnova's endometriosis blood test.

She explains HerResolve™, walks through three patient cases, and discusses how the results are informing next steps in evaluation.

Thank you, Dr. Palmerola, for sharing your experience and helping patients understand their testing options!

Watch the reel for her perspective on HerResolve™ in practice: https://www.instagram.com/reels/Ddm2j6hTWzB/

10/14/2026

Heading to American Society for Reproductive Medicine? Let's talk endometriosis in fertility care! HerAnova will be in Baltimore for the ASRM 2026 Scientific Congress & Expo from October 24 to 28.

New this year: we can get your clinic set up to order HerResolve™ right at our booth! Visit us at Booth #1127 during exhibit hours, October 26-28, to meet our team and get started.

HerResolve™ is a non-invasive, LDT-validated, blood-based test that confirms endometriosis in women with unexplained infertility or other symptoms. It's available nationwide and already offered in 160+ clinics across the U.S. Ready to bring it to your patients?

We'll discuss clinical use cases involving unexplained infertility, individualized IVF planning, and treatment decisions, alongside real-world data from the first nine months since launch. Bring your questions and share your perspective!

Prefer to plan ahead or can't join us in Baltimore? We'd love to connect! Email [email protected] to schedule an individual meeting or a virtual meeting.

Congress details: https://asrmcongress.org/

10/07/2026

HerAnova is a finalist for the Femtech Company of the Year Award!

We're thrilled to be one of three companies shortlisted in the Health Tech World Awards 2026.

Women with endometriosis can spend years seeking a diagnosis while pain and often infertility disrupt work, relationships, and everyday life. That's why our work in endometriosis and infertility matters so deeply to us and why we're proud to see it recognized.

This milestone gives us a moment to celebrate the research, persistence, and collaboration behind our progress. We're grateful to our team and the healthcare professionals working alongside us to advance women's health.

Thank you, Health Tech World, for recognizing HerResolve™, the first commercially available non-invasive blood-based endometriosis test in the U.S., and including HerAnova on this year's shortlist! Congratulations to our fellow finalists, Natural Cycles and SheMed.

Read the full shortlist announcement: https://htworld.co.uk/health-tech-world-awards/three-femtech-companies-shortlisted-for-health-tech-world-award-ftcat/

10/05/2026

What does it take to build a women's health therapeutic pipeline?

HerAnova's Chief Scientific Officer, Marcel van Duin, PhD, brings more than 30 years of pharmaceutical R&D leadership in women's health and reproductive medicine.

His experience spans senior roles at Organon, Ferring, Merck, and Schering-Plough. Dr. van Duin has contributed to R&D strategies and product pipelines, and his work includes nearly 100 manuscripts, abstracts, and patents.

At HerAnova, Dr. van Duin's experience helps guide our work to advance integrated solutions for endometriosis and infertility.

Meet the rest of our team: https://heranova.com/about-us/

10/01/2026

It's not you, it's endometriosis™.

For too long, severe period pain and other possible symptoms of endometriosis have been dismissed as "just a bad period", leaving many people facing years of uncertainty.

Pain is not drama or weakness, and no one should be expected to push through it in silence.

Open conversations can help replace doubt with understanding and encourage people to speak with a healthcare provider.

To everyone still searching for answers: we see you, and we remain committed to transforming women's health.

09/25/2026

What makes endometriosis so hard to detect, even when its impact is unmistakable?

In Nature Biotechnology, Carrie Arnold explores the search for biological clues in blood and menstrual fluid, including HerAnova's blood-based approach.

Our Chief Medical Officer – Head of Diagnostics, Farideh Bischoff, PhD, shares why diagnosis remains a major unmet need and why a single biological marker may not be enough to detect a complex disease.

Read what researchers are looking for, and why it matters: https://www.nature.com/articles/s41587-026-03265-3

09/23/2026

When you're seeking answers about endometriosis, the cost of testing may be on your mind, too.

Flexible Spending Account (FSA) and Health Savings Account (HSA) funds can be used toward the cost of HerResolve™, our blood-based test designed to aid in diagnosing endometriosis in symptomatic women.

If you're considering testing, your healthcare provider can help determine whether HerResolve™ is appropriate for you.

Patients and healthcare providers can learn about testing and connect with our team: https://heranova.com/products/

09/22/2026

September is Pain Awareness Month. At HerAnova, we listened to women who lived with endometriosis pain for years before receiving a diagnosis. Their experiences underscored the need for more ways to help patients find answers.

To help address that need, we developed HerResolve™, our non-invasive, blood-based test intended to assist healthcare providers in diagnosing endometriosis as part of a comprehensive diagnostic approach.

For us, supporting women means taking their experiences seriously and turning what we hear into action.

Learn more about HerResolve™: https://heranova.com/products/

09/18/2026

Navigating infertility often means making complex decisions with incomplete information.

If you're wondering whether endometriosis could be part of the picture, consider asking your fertility specialist:

• Could my symptoms or medical history suggest endometriosis?
• Would additional evaluation affect my treatment plan?
• What are the benefits and limitations of the available diagnostic options?

Every fertility journey is different. A thoughtful discussion can support individualized care.

Learn more about endometriosis and infertility from the American Society for Reproductive Medicine: https://www.reproductivefacts.org/news-and-publications/fact-sheets-and-infographics/endometriosis-does-it-cause-infertility/

Address

2 Burlington Woods Drive Suite 100
Burlington, MA
01803

Telephone

+18884891808

Website

http://heranova.com/

Alerts

Be the first to know and let us send you an email when HerAnova Lifesciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to HerAnova Lifesciences:

Want your business to be the top-listed health & beauty business in Burlington?